Soleus Capital Management, L.P. Immunic, Inc. Transaction History
Soleus Capital Management, L.P.
- $1.29 Billion
- Q2 2025
A detailed history of Soleus Capital Management, L.P. transactions in Immunic, Inc. stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 7,293,007 shares of IMUX stock, worth $6.2 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
7,293,007
Previous 7,293,007
-0.0%
Holding current value
$6.2 Million
Previous $7.95 Million
35.78%
% of portfolio
0.4%
Previous 0.66%
Shares
4 transactions
Others Institutions Holding IMUX
# of Institutions
62Shares Held
50MCall Options Held
13.2KPut Options Held
60.6K-
Abrdn PLC8.24MShares$7.01 Million0.01% of portfolio
-
Bvf Inc San Francisco, CA7.65MShares$6.51 Million0.21% of portfolio
-
Avidity Partners Management LP Dallas, TX5.62MShares$4.77 Million1.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$3.51 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.63MShares$3.08 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $26M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...